Emily's Entourage » Leadership Team

Our leadership team is made up of individuals who are the top minds in their fields and who have paved the way for the work that Emily’s Entourage is doing.

Bob Adelson, ESQ

Owner, Osage Partners

Bob founded Osage Partners in 1990 and has built a track record as a top-performing venture investor. He is a native of Tulsa, Oklahoma, where he is a partner in a fourth generation family business. Prior to founding Osage, Bob clerked with the honorable Walter K. Stapleton, U.S. Third Circuit Court of Appeals, and practiced corporate law at the Philadelphia law firm of Wolf, Block, Schorr & Solis-Cohen. He is a graduate of The Yale Law School, where he was an editor of The Yale Law Journal, and of Yale College, from which he graduated summa cum laude.

Bob is a trustee of Thomas Jefferson University, where he chairs the Innovation Pillar, and is a former Chair of Thomas Jefferson University Hospital and trustee of its former parent, Jefferson Health System. He serves on the Board of Directors of the Free Library of Philadelphia Foundation, is a member of the Advisory Council of the Yale Entrepreneurial Institute and serves on the Investment Committee of the Philadelphia Museum of Art and on the Business Development Committee of The Wistar Institute. Bob has served as a past member of The Yale Law School Fund, as a trustee of the Board of Friends Central School and as a former President of the Board of Trustees of The Philadelphia School.

Bob has been a board member of several private companies, and currently is on the boards of Halfpenny Technologies and Collections Marketing Center. Bob and his wife Marta reside in Merion, PA. They have three grown children.

Mark Fishman

CEO of TRF Holdings, LLC

Mark Fishman is currently the CEO of TRF Holdings, LLC, a small investment company. Mark was the executive director of Global Brands Group USA. He was formerly CEO and chairman of Fishman & Tobin, Inc., a Philadelphia-based clothing manufacturing company. Fishman & Tobin was a family-owned business started in 1914 and was sold at the end of 2011 to Li and Fung. In 2014, it was spun off as part of Global Brands Group. Today, the company sells to every major retailer in the United States, including Wal-Mart, Sears, Macy’s, JCPenney, Amazon, and Dillard’s to name a few. Mark came to the firm in 1978 directly after law school. He held a variety of positions and became president in 1985. He assumed the role of Chairman in 2005.

Mark has served on the board of The Children’s Hospital of Philadelphia (CHOP) for over 30 years, the last 10 as its Vice Chairman. He is currently on the Foundation Board of Overseers at CHOP and is co-chairing a new billion-dollar campaign. Mark also served on the Board of Visitors of Duke Law School for 10 years and is now a lifetime member. Mark serves on the boards of the Brodsky Research Institute at Johns Hopkins, the Center for Leadership and Learning (CLAL) in New York, and Atidim (an Israeli charity that educates the poor). He is also a Lifetime Trustee at Federation of Jewish Agencies of Greater Philadelphia and current Vice President of that organization.

Kevin Foskett, PhD

Chair, Department of Physiology
Isaac Ott Professor of Physiology
Perelman School of Medicine, University of Pennsylvania

J. Kevin Foskett, PhD, is the Isaac Ott Professor of Physiology and Chair of the Department of Physiology in the Perelman School of Medicine at the University of Pennsylvania. He is also Professor in the Department of Cell and Developmental Biology, and a member of the Mahoney Institute for Neurosciences and the Abramson Cancer Center. Dr. Foskett has been a stalwart member of Penn Medicine for nearly 20 years. After earning his doctorate at the University of California, Berkeley, he held positions at Toronto’s Hospital for Sick Children and at the University of Toronto before coming to Penn.

Dr. Foskett’s research for over 30 years has focused on the mechanisms and regulation of ion transport and signal transduction. He has had long standing interest in exocrine epithelial ion and water transport, with a particular focus on the genetic disease cystic fibrosis, and has published extensively on various aspects of the biophysics and cell biology of CFTR and the cell biology of lung submucosal glands, the site of the primary defect in the lungs in CF. He served as a consultant to the Cystic Fibrosis Foundation in their collaboration with Aurora Biosciences/Vertex that directly led to the development of the first drug that targets the basic defect in cystic fibrosis.

Chandra Ghose, PhD

Chief Scientific Officer, Emily’s Entourage

As Chief Scientific Officer, Chandra defines EE’s research priorities and sets them into motion — directing critical research dollars toward the most promising ideas, consulting with EE’s Scientific Advisory Board and the broader scientific community, and working with key stakeholders across a variety of sectors. Before joining EE, Chandra founded Bioharmony Therapeutics, an early-stage biotech startup specializing in developing novel antimicrobials to combat drug-resistant bacterial infections. In advance of that, she worked at the Aaron Diamond AIDS Research Center, an affiliate of Rockefeller University, where she focused her research on developing life-saving vaccines. She was a postdoctoral fellow at Harvard Medical School in the Division of Infectious Diseases, Massachusetts General Hospital.

Chandra holds a PhD in microbiology from New York University School of Medicine and a bachelor’s degree from Saint Louis University in biology and theology. She is a Health Innovators Fellow at the Aspen Institute’s Global Leadership Network, and a Trustee at the Trinity School in New York. An avid volunteer and entrepreneur, Chandra is involved in a number of causes close to her heart, including Beyond Pads, a non-profit she founded that provides menstrual products to children living in shelters.

Born in Kolkata, India, Chandra now resides in New York City with her husband, daughter, and their pandemic puppy, Jaws.

Michael Golinkoff, PhD, MBA

Co-Founder of Emily’s Entourage
President of PerformCare

Michael graduated with a BA in psychology from Colgate University. He then earned a PhD in Developmental and Clinical Psychology from the University of Illinois-Chicago. He completed a pre- and post-doctoral internship at the New York Hospital-Cornell Medical Center-Westchester Division. Michael then completed the Executive MBA program at the Wharton School of the University of Pennsylvania.

Michael has been a clinical psychologist for over 30 years. He has spent the past 20 of them as a business executive running large national organizations with a focus on helping individuals receive high quality care. Currently Michael is the President of PerformCare, a national behavioral health company assisting Medicaid recipients.

Michael is a founding member of Emily’s Entourage and the proud father of Emily, Coby, Julia and Annie.

Liza Kramer, MSW

Co-Founder of Emily’s Entourage

Liza graduated from Colgate University in 1978. She received her master’s degree in social work from the Jane Addams School of Social Work at the University of Illinois.

Before leaving the professional workforce to raise four kids, Liza worked as a teacher and at a variety of social service agencies helping children and families with special needs and delinquency. She had a particular interest in at-risk juveniles and worked closely with the juvenile court system.

Since co-founding Emily’s Entourage in 2011, Liza has worked tirelessly to help run and oversee all aspects of the foundation.

Liza is the proud mother of Emily, Coby, Julia and Annie

Emily Kramer-Golinkoff, MBE

Co-Founder of Emily’s Entourage

As an adult with cystic fibrosis, Emily is both the inspiration behind and co-founder of Emily’s Entourage. She is also an internationally recognized patient advocate and speaker with a professional background in digital health innovation and marketing.

Emily has a master’s degree in bioethics and certification in clinical ethics mediation from the University of Pennsylvania, where she also completed her undergraduate degree. She has given talks at The White House, TEDx, University of Pennsylvania’s Annenberg School for Communication Commencement, Stanford University’s Medicine X Conference, and more.

Emily was named a “Champion of Change” for President Obama’s Precision Medicine Initiative and is the recipient of the 2020 Philadelphia Magazine Luminary Award and the 2016 Global Genes Rare Champion of Hope for Advocacy Award.

Greg Reh, MS

Deloitte Global Life Sciences & Health Care Leader

Greg is a principal at Deloitte Consulting LLP and leads the Firm’s US Life Sciences Consulting practice. In his role he is responsible for the delivery of all consulting services to the portfolio of life sciences clients, practice operations and the development of solutions, methods and research related to the transformation of life sciences companies.

Greg has more than 25 years of experience in the life sciences, process manufacturing, consumer and government sectors. His consulting career has spanned such topics as technology strategy, integration solution development and implementation of emerging and disruptive technology. His clients have included multinational pharmaceutical, biotechnology and chemical manufacturing organizations where he successfully led consulting services in support of regulatory, clinical, commercialization and manufacturing operations.

Prior to his consulting career Greg held positions at a government research lab, where he led teams in the design and development of life support devices; and was a lecturer at the University of Pennsylvania.

Greg holds an MS from the University of Pennsylvania, and a BSME from Drexel University.

David B. Weiner, PhD

Executive Vice President, The Wistar Institute; Director – Wistar Vaccine Center; W.W. Smith Charitable Trust Professor in Cancer Research

Preeminent immunologist and vaccine expert, David B. Weiner, Ph.D., is executive vice president of The Wistar Institute, director of the Wistar Vaccine Center, and the W. W. Smith Charitable Trust Professor in Cancer Research. Dr. Weiner directs a translational research laboratory in the area of Molecular Immunology. His group is one of the pioneering research teams in establishing the field of DNA vaccines and immune therapies. Important reports from his lab include the first DNA vaccine studied for HIV as well as for cancer immune therapy, the early development of DNA encoded genetic adjuvants including the particularly relevant IL-12, advances in gene optimization, and advances in electroporation technologies resulting in improved gene delivery among others. His group worked with collaborators to become the first to move DNA technology into human study. His laboratory’s work helped revitalize the field through advancement of new synthetic DNA design and modification of EP delivery approaches resulting in potent immune induction as well as the first successful Phase IIb DNA efficacy study (for HPV immune therapy) in humans.

Weiner is the recipient of numerous honors including election as a fellow to both the American Association for the Advancement of Science in 2011 and the International Society for Vaccines in 2012. He is the recipient of the NIH Director’s Transformative Research Award and received the Vaccine Industry Excellence Award for Best Academic Research Team in 2015 at the World Vaccine Congress. Weiner was honored with the prestigious Hilleman Lectureship in 2015 at the Children’s Hospital of Philadelphia Grand Rounds session and received a Stone Family Award from Abramson Cancer Center for his groundbreaking work on DNA vaccines for cancer immune therapy.

In March 2016, Weiner returned to Wistar from his position at The University of Pennsylvania School of Medicine as professor of Pathology and Laboratory Medicine. From 1990 to 1993, Weiner held a joint position as assistant professor of Pathology and Laboratory Medicine at The Wistar Institute and the University of Pennsylvania School of Medicine.

Weiner graduated with a B.S. in biology from SUNY at Stony Brook, in Stony Brook, N.Y., a M.S. in biology from the University of Cincinnati and a Ph.D. in developmental biology from the University of Cincinnati College of Medicine.